Article
Is The Trump Administration All In On Psychedelics?
The Trump administration has signaled growing support for psychedelic medicine through a recent executive order and cabinet-level statements, focusing particularly on ibogaine research for treating PTSD, opioid dependence, and other mental health conditions in veterans. While these developments represent meaningful institutional backing, significant legal and regulatory obstacles remain before psychedelics can move from Schedule I classification to approved medical treatments.
Bradley Arant Boult Cummings LLP
